Trial Profile
A multi-centre phase II controlled study of Vx-001 in Non Small Cell Lung Cancer (NSCLC)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2011
Price :
$35
*
At a glance
- Drugs Vx 001 (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 Jun 2011 New trial record